Development Project Grants
Request for applications
Alzheimer’s Disease Development Grants
The Boston University Alzheimer’s Disease Center (BU ADC)
Is Soliciting Proposals for Pilot and Feasibility Studies
New proposals or initiatives for biomedical, epidemiological behavioral, legal, ethical, health systems or other research in Alzheimer’s disease are encouraged. Two NIH funded proposals for $25,000 indirect costs for one-year non-renewable studies will be awarded. The Development Grant funding mechanism is intended to support new investigators from other fields eager to bring their expertise to bear on Alzheimer’s disease, as well as feasibility testing of novel research to develop preliminary data for larger grant applications. Development study support is not intended for large undertakings by established investigators, or to enhance ongoing research projects that are already funded.
A PDF version of the proposal on an NIH PHS 398 form is due on January 10, 2020 (URL for the form: http://grants.nih.gov/grants/funding/phs398/phs398.html). (Please combine all required PDFs into one PDF). There is a 5 page maximum for the specific aims, background, preliminary results and experimental methods sections. No appendices are allowed. All proposals should be accompanied by at least preliminary animal, human studies and/or biohazard forms if applicable. (If your study is based on human subjects, a Target Enrollment form must be included with your application). Signatures from department or administrative officials are NOT required.
The completed proposal should be e-mailed to firstname.lastname@example.org. At least two expert reviewers will review and score each grant based on scientific merit, and the Executive Committee will make funding decisions based on these scores and program priorities. The selected grants will be funded from July 1, 2020 through June 30, 2021.
No adjustments to this funding period and no carry-over of funds are allowed. Proposals that utilize the BU ADC’s resources or data (including the participant registry and/or the brain bank) and grants involving Chronic Traumatic Encephalopathy (CTE) are strongly encouraged. Partnerships with a community-based organizations, including resources directed toward the recruitment and retention of diverse research participants, are strongly encouraged as well.
It is critical to our future funding that you cite our NIH grant number P30-AG013846 on any publications, abstracts, or manuscripts that resulted from this project.
For specific program guideline or additional information regarding the BU ADC Development Grant program, contact: Beverly Young, Administrator, E-mail: email@example.com, Tel: (857) 364-4702.